Esportazioa burutua — 

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

BACKGROUND: The emergence of new therapies for the treatment of rheumatoid arthritis (RA), the paucity of head-to-head studies, and the heterogeneous nature of responses to current biologics highlight the need for the identification of prognostic factors for treatment response and retention in clini...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Musculoskelet Disord
Egile Nagusiak: Nüßlein, Hubert G., Alten, Rieke, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T., Bensen, William G., Burmester, Gerd R., Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Melanie, Poncet, Coralie, Rauch, Christiane, Le Bars, Manuela
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4521342/
https://ncbi.nlm.nih.gov/pubmed/26228643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-015-0636-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak